Decitabine With Venetoclax vs Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ten-Day Decitabine With Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score-Matched Analysis
Cancer 2021 Aug 03;[EPub Ahead of Print], A Maiti, CD DiNardo, W Qiao, TM Kadia, EJ Jabbour, CR Rausch, NG Daver, NJ Short, G Borthakur, N Pemmaraju, M Yilmaz, Y Alvarado, KS Montalbano, A Wade, RE Maduike, JA Guerrero, K Vaughan, CA Bivins, S Pierce, J Ning, F Ravandi, HM Kantarjian, MY KonoplevaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.